This page shows prior authorization criteria extracted from Aetna's published imaging guidelines. 81 matching coverage rules found for this procedure.
Abnormal Blood Clotting
Indication Code: HD-11.9
Achondroplasia
Indication Code: PEDSP-7.1
Acute Lymphoblastic Leukemia (ALL)
Indication Code: PEDONC-3.2
Advanced Imaging Indications Related To Migraines
Indication Code: HD-11.17
Arteriovenous Malformations (AVMs) and Related Lesions
Indication Code: HD-12.2
Ataxia
Indication Code: PEDHD-20.1
Ataxia
Indication Code: HD-3.1
Atypical Teratoid/Rhabdoid Tumors (ATRT)
Indication Code: PEDONC-4.5
Autoimmune/Paraneoplastic Encephalitis & Neuroinflammatory Disorders
Indication Code: HD-14.3
Basilar Impression/Basilar Invagination
Indication Code: HD-5.4
Behavioral and Psychiatric Disorders
Indication Code: PEDHD-18.1
Cerebral Venous Sinus Thrombosis
Indication Code: HD-21.8
Chiari III and IV Malformations
Indication Code: HD-5.3
CNS and Head Infection
Indication Code: HD-14.1
CNS Germinomas and Non-Germinomatous Germ Cell Tumors (NGGCT)
Indication Code: PEDONC-4.7
CNS High Grade Gliomas (HGG)
Indication Code: PEDONC-4.3
CNS Infection
Indication Code: PEDHD-29.1
CNS Low Grade Gliomas (LGG)
Indication Code: PEDONC-4.2
Craniopharyngioma and Other Tumors of the Sellar Region
Indication Code: PEDONC-4.10
Craniosynostosis Imaging
Indication Code: PEDHD-8.1
CT or MRI Perfusion
Indication Code: HD-24.5
Dizziness/Vertigo
Indication Code: HD-23.1
Empty Sella Turcica
Indication Code: HD-19.3
Epilepsy/Seizures
Indication Code: HD-9.1
Eye Disorders and Visual Loss
Indication Code: HD-32.1
Facial Trauma
Indication Code: PEDHD-4.2
Facial Trauma
Indication Code: HD-13.2
Febrile Seizures
Indication Code: PEDHD-6.4
General Guidelines
Indication Code: ONC-1.0
General Guidelines
Indication Code: PEDONC-1.0
General Guidelines
Indication Code: HD-1.0
General Guidelines – CT Head
Indication Code: HD-1.4
General Guidelines – Modality
Indication Code: HD-1.2
Head Trauma
Indication Code: PEDHD-4.1
Head Trauma
Indication Code: HD-13.1
Headache General Guidelines
Indication Code: HD-11.0
Headaches Associated With Head Trauma
Indication Code: HD-11.12
Hydrocephalus Shunts
Indication Code: HD-11.14
Hydrocephalus, Shunts, and Endoscopic Third Ventriculostomy (ETV)
Indication Code: PEDHD-7.3
Imaging Indications in Sinusitis
Indication Code: PEDHD-5.2
Initial Imaging of Non-Febrile Seizures
Indication Code: PEDHD-6.1
Key Principles
Indication Code: ONC-1.1
Low-Pressure Headache and CSF Leak
Indication Code: HD-11.15
Macrocephaly
Indication Code: PEDHD-7.1
Medulloblastoma (MDB), Other CNS Embryonal Tumors, and Pineoblastoma
Indication Code: PEDONC-4.4
Mental Health Related Disorders
Indication Code: HD-4.1
Mental Status Change
Indication Code: HD-4.2
Mild Cognitive Impairment (MCI) and Dementia - MRI/CT
Indication Code: HD-8.1
Movement Disorders
Indication Code: HD-15.1
Neuro-COVID-19 and Sars-CoV-2 Vaccines
Indication Code: HD-14.2
Neuroblastoma – Initial Staging
Indication Code: PEDONC-6.3
Neuronavigation
Indication Code: HD-28.2
New Headache Onset Older than Age 50
Indication Code: HD-11.7
Non-Small Cell Lung Cancer – Initial Work-up/Staging
Indication Code: ONC-8.3
Normal Pressure Hydrocephalus (NPH)
Indication Code: HD-8.4
Papilledema/Pseudotumor Cerebri
Indication Code: HD-17.1
Pediatric Head Imaging Modality General Considerations
Indication Code: PEDHD-1.3
Pediatric Headache
Indication Code: PEDHD-3.1
Pediatric Intracranial Aneurysms and Subarachnoid Hemorrhage
Indication Code: PEDHD-10.1
Pediatric Intracranial Arteriovenous Malformations (AVM)
Indication Code: PEDHD-10.2
Pediatric Leukemia General Considerations
Indication Code: PEDONC-3.1
Pediatric Lymphoma – General Considerations
Indication Code: PEDONC-5.1
Pediatric NPC – Imaging
Indication Code: PEDONC-13.2
Pediatric Stroke Initial Imaging
Indication Code: PEDHD-12.2
Physical Exertion
Indication Code: HD-11.11
Pituitary
Indication Code: HD-19.1
Platybasia
Indication Code: HD-5.5
Post-Operative Imaging
Indication Code: HD-28.3
Post-Transplant Imaging
Indication Code: PEDONC-20.2
Pregnancy
Indication Code: HD-11.10
Primary Central Nervous System Tumors – General Considerations
Indication Code: ONC-2.1
Scalp and Skull Lesions
Indication Code: PEDHD-30.1
Scalp and Skull Lesions
Indication Code: HD-20.1
Skull Base, Orbit, Periorbital or Oromaxillary
Indication Code: HD-11.5
Spinal Dysraphism
Indication Code: PEDSP-4.4
Stroke/TIA
Indication Code: HD-21.1
Sudden Onset of Headache
Indication Code: HD-11.3
Suspected Physical Child Abuse
Indication Code: PEDMS-7
Syncope
Indication Code: HD-23.2
Systemic Infections
Indication Code: HD-11.13
Thyroid Cancer – Initial Work-up/Staging
Indication Code: ONC-6.2
Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.
Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.
⚠ This study uses ionizing radiation. Payers may ask that non-ionizing alternatives (MRI, ultrasound) be considered first when clinically appropriate.